Adverse Effects Of Sglt2 Inhibitors In Older Patients With Congestive Heart Failure And The Influence Of Chronic Kidney Disease

被引:0
|
作者
Mahmood, Riaz [1 ]
Robinson, Shane
Kilaru, Vikas [2 ]
Amoran, Olayiwola
Egolum, Ugochukwu [3 ]
机构
[1] Northeast Georgia Hlth Syst, Suwanee, GA USA
[2] GHI NGHS, Gainesville, GA USA
[3] Northeast Georgia Hlth Syst, Buford, GA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
249
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Congestive Heart Failure in Patients with Chronic Kidney Disease
    Poskurica, Mileta
    Petrovic, Dejan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2014, 142 (11-12) : 747 - 755
  • [32] SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction
    Julie Hias
    Laura Hellemans
    Karolien Walgraeve
    Jos Tournoy
    Lorenz Van der Linden
    Drugs & Aging, 2022, 39 : 185 - 190
  • [33] SGLT2 Inhibitors slow down the Progression of chronic Kidney Disease
    不详
    NEPHROLOGE, 2019, 14 (03): : 225 - 225
  • [34] SGLT2 Inhibitors in Diabetic Kidney Disease
    Zoungas, Sophia
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (04): : 631 - 633
  • [35] SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction
    Hias, Julie
    Hellemans, Laura
    Walgraeve, Karolien
    Tournoy, Jos
    Van der Linden, Lorenz
    DRUGS & AGING, 2022, 39 (03) : 185 - 190
  • [36] SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review
    Maxson, Rebecca
    Starr, Jessica
    Sewell, Jeanna
    Lyas, Claretha
    CLINICAL THERAPEUTICS, 2024, 46 (01) : e23 - e28
  • [37] Do four SGLT2 inhibitors lead to different cardiorenal benefits in type 2 diabetes, in chronic heart failure, and in chronic kidney disease?
    Qiu, Mei
    Ding, Liang-Liang
    Zhan, Ze-Lin
    Zhou, Hai-Rong
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 87 : 98 - 99
  • [38] The cardiovascular effects of SGLT2 inhibitors, RAS inhibitors, and ARN inhibitors in heart failure
    Ji, Peng-juan
    Zhang, Zhuo-ya
    Yan, Qi
    Cao, Hui-li
    Zhao, Ya-jing
    Yang, Bing
    Li, Jin
    ESC HEART FAILURE, 2023, 10 (02): : 1314 - 1325
  • [39] SGLT2 inhibitors and the kidney: Effects and mechanisms
    Tsimihodimos, V.
    Filippatos, T. D.
    Elisaf, M. S.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (06) : 1117 - 1123
  • [40] Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors
    Butler, Javed
    Rich, Jonathan
    JACC-HEART FAILURE, 2024, 12 (06) : S1 - S3